Chemia Biosciences spun out of Carnegie Mellon University, School of Computer Science. Chemia’s platform is based on cutting-edge methods developed by Drs Hosein Mohimani and Bahar Behsaz. Cheima Bio’s platform finds novel small molecules that can function as drug leads targeting drug-resistant and orphan diseases, and new crop protection molecules. Chemia’s platform has already led to the discovery of multiple novel bioactive molecules.